How can live bacteria prevent and treat disease? – general aspects and recent advances on the development of Live Biotherapeutic Products (LBPs)

Program

• Welcome and introduction
• Population-based microbiome profiling for identification of the optimal LBPs, Lars Engstrand
• Taking an LBP (REBYOTA) to the market, Anne-Sophie Sundström
• Lactic Acid Bacterial based LBP’s – Preclinical research, Product development and early phase Clinical testing, Stefan Roos
• Discussion
• Summary and closing

Speaker

Lars Engstrand, Professor, MD, senior consultant Director, Centre for Translational Microbiome Research, CTMR Karolinska Institutet

Anne-Sophie Sundström, Senior Product Development Manager, Ferring Pharmaceuticals A/S

 Stefan Roos, Adjunct Professor SLU, Swedish University of Agricultural Sciences, Director Preclinic & Discovery, BioGaia AB and Co-founder and associated to Ilya Pharma AB

This is organized by section of drug formulation, this will be held in English!

Time & place

27 november
Kl. 17..00-19.00
Via zoom!